Robeco Institutional Asset Management B.V. trimmed its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 22.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 144,904 shares of the financial services provider's stock after selling 41,457 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in MetLife were worth $11,865,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Sanctuary Advisors LLC purchased a new stake in MetLife in the second quarter worth $6,377,000. Massmutual Trust Co. FSB ADV increased its position in MetLife by 7.5% in the third quarter. Massmutual Trust Co. FSB ADV now owns 2,342 shares of the financial services provider's stock worth $193,000 after buying an additional 164 shares during the last quarter. Czech National Bank increased its position in MetLife by 5.3% in the third quarter. Czech National Bank now owns 119,837 shares of the financial services provider's stock worth $9,884,000 after buying an additional 6,007 shares during the last quarter. Wright Investors Service Inc. increased its position in MetLife by 1.5% in the third quarter. Wright Investors Service Inc. now owns 21,548 shares of the financial services provider's stock worth $1,777,000 after buying an additional 327 shares during the last quarter. Finally, Handelsbanken Fonder AB increased its position in MetLife by 50.0% in the third quarter. Handelsbanken Fonder AB now owns 109,120 shares of the financial services provider's stock worth $9,000,000 after buying an additional 36,367 shares during the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.
MetLife Price Performance
NYSE:MET opened at $86.56 on Friday. The firm has a market capitalization of $59.93 billion, a price-to-earnings ratio of 17.45, a P/E/G ratio of 0.66 and a beta of 1.07. MetLife, Inc. has a 52-week low of $64.61 and a 52-week high of $89.05. The stock has a fifty day moving average of $84.06 and a 200 day moving average of $80.39. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.52%. The ex-dividend date is Tuesday, February 4th. MetLife's dividend payout ratio (DPR) is currently 43.95%.
Analysts Set New Price Targets
A number of analysts have issued reports on the company. Wells Fargo & Company decreased their target price on MetLife from $93.00 to $92.00 and set an "overweight" rating for the company in a research report on Tuesday, January 14th. Barclays raised their target price on MetLife from $90.00 to $96.00 and gave the stock an "overweight" rating in a research report on Monday, January 6th. JPMorgan Chase & Co. raised their price target on MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a report on Tuesday, January 7th. StockNews.com lowered MetLife from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Finally, BMO Capital Markets began coverage on MetLife in a report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price target for the company. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $90.46.
View Our Latest Analysis on MetLife
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.